MedTrace Logo

Treatment of Upper and Lower Respiratory Tract Infections in Young Children Using Probiotic

NCT04122495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-04-29

No results posted yet for this study

Summary

This project aims to study the benefits of probiotics namely Bifidobacterium lactis M8 in treatment of upper and lower respiratory tract infections in young children, which are found common among children in Malaysia aged from 0-24 months.

Conditions

  • Respiratory Infection (for Example, Pneumonia, Bronchitis)

Interventions

DIETARY_SUPPLEMENT

Probiotic

Oral administration of B. lactis M8 at 10 log CFU/day for 4-weeks

DIETARY_SUPPLEMENT

Placebo

Oral administration of maltodextrin daily for 4-weeks

Sponsors & Collaborators

  • Beijing Scitop Bio-Tech Shareholding Co.Ltd.

    collaborator UNKNOWN

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Min Tze Liong, PhD · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-29
Primary Completion
2020-11-03
Completion
2020-11-03

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122495 on ClinicalTrials.gov